Reteplase Superior to Alteplase in Chinese Stroke Trial

The double-bolus thrombolytic gave a higher rate of excellent functional outcomes in the RAISE trial.
Medscape Medical News

source https://www.medscape.com/viewarticle/reteplase-superior-alteplase-chinese-stroke-trial-2024a1000c55?src=rss